CFTR 5T variant has a low penetrance in females that is partially attributable to its haplotype.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 16778595)

Published in Genet Med on June 01, 2006

Authors

Weimin Sun1, Ben Anderson, Joy Redman, Aubrey Milunsky, Arlene Buller, Matthew J McGinniss, Franklin Quan, Arturo Anguiano, Stephen Huang, Feras Hantash, Charles Strom

Author Affiliations

1: Department of Molecular Genetics, Quest Diagnostics Nichols Institute, San Juan Capistrano, California 92690, USA.

Articles by these authors

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61

Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell (2011) 4.89

Eater, a transmembrane protein mediating phagocytosis of bacterial pathogens in Drosophila. Cell (2005) 3.22

TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine. Cell Res (2010) 2.11

Molecular screening for diseases frequent in Ashkenazi Jews: lessons learned from more than 100,000 tests performed in a commercial laboratory. Genet Med (2004) 1.89

Cystic fibrosis screening using the College panel: platform comparison and lessons learned from the first 20,000 samples. Genet Med (2002) 1.60

Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. N Engl J Med (2013) 1.56

Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci U S A (2007) 1.54

Cystic fibrosis screening: lessons learned from the first 320,000 patients. Genet Med (2004) 1.48

The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure. J Biol Chem (2003) 1.45

Detection of 677CT/1298AC "double variant" chromosomes: implications for interpretation of MTHFR genotyping results. Genet Med (2005) 1.44

In defense of commercial laboratories. Genet Med (2005) 1.39

A girl with goiter and inappropriate thyroid-stimulating hormone secretion. Clin Chem (2008) 1.36

Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases. Blood (2005) 1.35

Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project. J Mol Diagn (2010) 1.34

Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: implications for fragile X syndrome carrier and newborn screening. Genet Med (2010) 1.34

In vivo dimerization of types 1, 2, and 3 iodothyronine selenodeiodinases. Endocrinology (2003) 1.34

FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States. Genet Med (2011) 1.25

Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression. J Immunol (2012) 1.23

A genome-wide scan for primary open-angle glaucoma (POAG): the Barbados Family Study of Open-Angle Glaucoma. Hum Genet (2003) 1.21

A novel technique for stenting pulmonary artery and conduit bifurcation stenosis. Catheter Cardiovasc Interv (2011) 1.15

Extensive sequencing of the cystic fibrosis transmembrane regulator gene: assay validation and unexpected benefits of developing a comprehensive test. Genet Med (2003) 1.14

Novel roles for KLF1 in erythropoiesis revealed by mRNA-seq. Genome Res (2012) 1.13

Preimplantation diagnosis for p53 tumour suppressor gene mutations. Reprod Biomed Online (2001) 1.13

Technology challenges in screening single gene disorders. Eur J Pediatr (2003) 1.09

Aberrant cell cycle and apoptotic changes characterise severe influenza A infection--a meta-analysis of genomic signatures in circulating leukocytes. PLoS One (2011) 1.09

Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screening. Hum Genet (2005) 1.07

Molecular testing for Fragile X Syndrome: lessons learned from 119,232 tests performed in a clinical laboratory. Genet Med (2007) 1.06

Extensive sequencing of the CFTR gene: lessons learned from the first 157 patient samples. Hum Genet (2005) 1.05

Contrasting phenotypes in three patients with novel mutations in mitochondrial tRNA genes. Mol Genet Metab (2004) 1.04

Cystic fibrosis testing 8 years on: lessons learned from carrier screening and sequencing analysis. Genet Med (2011) 1.01

Gene sequencing in neonates and infants with the long QT syndrome. Genet Test (2005) 0.97

Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. Appl Microbiol Biotechnol (2013) 0.96

Technical validation of a TM Biosciences Luminex-based multiplex assay for detecting the American College of Medical Genetics recommended cystic fibrosis mutation panel. J Mol Diagn (2006) 0.95

Consumptive hypothyroidism resulting from hepatic vascular tumors in an athyreotic adult. J Clin Endocrinol Metab (2011) 0.95

Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses. Pancreas (2011) 0.95

Half-molar sodium lactate infusion improves cardiac performance in acute heart failure: a pilot randomised controlled clinical trial. Crit Care (2014) 0.94

Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory. Genet Med (2011) 0.94

A large deletion in the CFTR gene in CBAVD. Genet Med (2006) 0.93

IL-6 production is positively regulated by two distinct Src homology domain 2-containing tyrosine phosphatase-1 (SHP-1)-dependent CCAAT/enhancer-binding protein β and NF-κB pathways and an SHP-1-independent NF-κB pathway in lipopolysaccharide-stimulated bone marrow-derived macrophages. J Immunol (2011) 0.90

Development of genomic DNA reference materials for genetic testing of disorders common in people of ashkenazi jewish descent. J Mol Diagn (2009) 0.89

Sickle Cell Disease. N Engl J Med (2017) 0.88

Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors. J Genet Couns (2005) 0.88

Technical validation of a multiplex platform to detect thirty mutations in eight genetic diseases prevalent in individuals of Ashkenazi Jewish descent. Genet Med (2005) 0.87

Development of genomic reference materials for Huntington disease genetic testing. Genet Med (2007) 0.86

Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. Am J Hum Genet (2004) 0.85

Frequency of the cystic fibrosis 3199del6 mutation in individuals heterozygous for I148T. Genet Med (2004) 0.84

Molecular characterization of the TCP11 gene which is the human homologue of the mouse gene encoding the receptor of fertilization promoting peptide. Mol Hum Reprod (2002) 0.83

Direct visualization of cystic fibrosis transmembrane regulator mutations in the clinical laboratory setting. Clin Chem (2004) 0.83

Prevalence of known mutations in the familial Mediterranean fever gene (MEFV) in various carrier screening populations. Genet Med (2008) 0.83

Analysis by mass spectrometry of 100 cystic fibrosis gene mutations in 92 patients with congenital bilateral absence of the vas deferens. Hum Reprod (2002) 0.82

Folate intake and the risk of neural tube defects: an estimation of dose-response. Epidemiology (2003) 0.82

Development of a web-based query tool for quality assurance of clinical molecular genetic test results. J Mol Diagn (2007) 0.82

Chromosomal anomalies among the offspring of women with gestational diabetes. Am J Epidemiol (2002) 0.82

A fourteen years follow-up of a case of partial trisomy 12q and monosomy 12p recombinants of a familial pericentric inversion of chromosome 12: clinical, cytogenetic and molecular observations. Eur J Med Genet (2007) 0.82

Controlled loading of building blocks into temporary self-assembled scaffolds for directed assembly of organic nanostructures. Langmuir (2008) 0.82

Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing. J Mol Diagn (2009) 0.81

Abnormal distribution and hyperplasia of thyroid C-cells in PTEN-associated tumor syndromes. Endocr Pathol (2004) 0.81

Correlation of abnormal rapid FISH and chromosome results from amniocytes for prenatal diagnosis. Fetal Diagn Ther (2006) 0.81

Characterization of a recurrent novel large duplication in the cystic fibrosis transmembrane conductance regulator gene. J Mol Diagn (2007) 0.80

Preimplantation diagnosis for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Reprod Biomed Online (2001) 0.80

Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles. Clin Gastroenterol Hepatol (2009) 0.80

Delayed puberty due to a novel mutation in CHD7 causing CHARGE syndrome. Pediatrics (2010) 0.80

Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi. Mod Pathol (2013) 0.80

Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors. J Genet Couns (2013) 0.79

Clinical, cytogenetic, and molecular characterization of a girl with some clinical features of Down syndrome resulting from a pure partial trisomy 21q22.11-qter due to a de novo intrachromosomal duplication. Genet Test Mol Biomarkers (2010) 0.79

A de novo complex chromosome rearrangement involving chromosomes 2, 3, 5, 9 and 11 detected prenatally and studied postnatally by conventional cytogenetics and molecular cytogenetic analyses. Fetal Diagn Ther (2007) 0.79

Fraternal twins with Aarskog-Scott syndrome due to maternal germline mosaicism. Am J Med Genet A (2011) 0.79

"Host tissue damage" signal ATP impairs IL-12 and IFNgamma secretion in LPS stimulated whole human blood. Intensive Care Med (2008) 0.77

Paternal mosaic inv(20) resulting in a recombinant chromosome 20 in two siblings. Pediatr Int (2010) 0.77

Whole gene duplication of the PQBP1 gene in syndrome resembling Renpenning. Am J Med Genet A (2010) 0.76

Multiple property tolerance analysis for the evaluation of missense mutations. Evol Bioinform Online (2007) 0.76

Hypoxic spinal cord injury and/or abnormality in utero. Pediatr Neurol (2007) 0.75

Rapid one-step carrier detection assay of mucolipidosis IV mutations in the Ashkenazi Jewish population. J Mol Diagn (2006) 0.75

A 14-year follow-up of a case detected prenatally of partial trisomy 13q21.32-qter and monosomy 18q22.3-qter as a result of a maternal complex chromosome rearrangement involving chromosomes 6, 13, and 18. Genet Test Mol Biomarkers (2009) 0.75

Impact of Viral Respiratory Pathogens on Outcomes After Pediatric Cardiac Surgery. Pediatr Crit Care Med (2017) 0.75

Genetic counseling, the ophthalmologist and the law. Metab Ophthalmol (1977) 0.75